Physician profile
Prashant Kaul
NPI 1932304656
$109,086.79
in general payments reported to CMS, 2019-2025
21 companies · $1,251 in 2025
The $1,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $21K · 2021: $5,583 · 2022: $18K · 2023: $25K · 2024: $5,988 · 2025: $1,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,650 · Consulting Fee: $4,425 · Food and Beverage: $2,050 · Travel and Lodging: $18.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,146.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,650.00 |
| Consulting Fee | $4,425.00 |
| Food and Beverage | $2,049.82 |
| Travel and Lodging | $18.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $55,177.44 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Abbott Laboratories | $18,587.46 | 2019-2025 | Diamondback Coronary, Esprit, Cardiomems |
| Shockwave Medical, INC | $14,732.51 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Philips North America LLC | $14,539.44 | 2019-2025 | Intellivue Information Center |
| Cordis US Corp. | $3,889.45 | 2023-2025 | Selution Slr Ptca, Saber, Mynx Control Venous |
| Biotronik INC. | $655.94 | 2021-2025 | Pk Papyrus |
| Novartis Pharmaceuticals Corporation | $499.50 | 2023-2025 | |
| Medtronic, INC. | $369.57 | 2023-2025 | Symplicity G3, Onyx Frontier, Hawkone |
| Boston Scientific Corporation | $186.09 | 2019-2024 | Avvigo Guidance System |
| Teleflex LLC | $132.74 | 2023 | Guideliner |
| Ekos Corporation | $93.15 | 2019 | |
| Pfizer INC. | $48.77 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $36.53 | 2025 | Eliquis |
| Cardiva Medical, INC. | $26.24 | 2024 | Optowire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.83 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $19.33 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.51 | 2022 | |
| Heartflow, INC. | $16.19 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals, Ltd. | $14.50 | 2023 | Arcalyst |
| Amgen INC. | $14.11 | 2025 | Repatha |
| Baylis Medical Company INC | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashant Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.